Clinical Topics

No Link Found Between H. Pylori Infection, Unexplained Anemia

by U.S. Medicine

May 21, 2018

SYRACUSE, NY — Despite limited evidence to support the practice, testing for Helicobacter pylori (Hp) infection is recommended for work-up of unexplained iron deficiency anemia (IDA).

A study published in the journal Gastroenterology Report sought to investigate the association between Hp infection and unexplained iron deficiency (ID) or IDA in the older adult population without significant upper gastrointestinal source of blood loss.1

“Peptic ulcer disease caused by Hp infection can lead to gastrointestinal blood loss and IDA,” wrote State University of New York (SUNY), Upstate Medical University-led researchers. “Whether Hp infection can lead to IDA in the absence of peptic ulcer disease is controversial. Most of the data supporting association of Hp infection and IDA come from clinical studies conducted in children and premenopausal women with a relatively high iron requirement and in those living in areas with a high prevalence for Hp infection.

“The majority of the epidemiological studies that support this association have used serologic tests that do not necessarily diagnose active Hp infection,” they added. “In addition, most of these studies have not ruled out the major causes of IDA, such as peptic ulcer disease by esophagogastroduodenoscopy (EGD). Thus, the applicability of the available study findings in adult population living in areas with low prevalence for Hp infection who are not vulnerable to ID is controversial. The available data supporting association between Hp infection and ID do not prove cause and effect.”

To clarify the connection, the study team conducted research involving collection of Hp infection data on 1,253 consecutive patients undergoing diagnostic or therapeutic upper gastrointestinal endoscopy at the Syracuse, NY, VAMC from Jan. 1, 1998, to April 28, 2004. They compared the Hp-positive and Hp-negative groups to identify significant risk factors associated with ID and IDA.

Researchers noted that 523 of them had no significant upper and/or lower gastrointestinal source for blood loss or risk factors for IDA.

Overall, 103 of the patients (19.7%) had Hp infection, and 420 (80.3%) were found to be negative for Hp. In addition, 68 (22.1%) out of 307 subjects with available serum iron profile had unexplained ID, and 28 (5.4%) out of 510 subjects with available hemoglobin profile had unexplained IDA. No association was found between ID/IDA and Hp infection in univariate and multiple logistic regression analyses, the researchers pointed out.

“We found no association between unexplained ID or IDA and Hp infection in older adult population without peptic ulcer disease or significant upper gastrointestinal source of blood loss,” the study authors concluded.


1Savio John, Juan Diego Baltodano, Nilesh Mehta, Katherine Mark, Uma Murthy; Unexplained iron deficiency anemia: does Helicobacter pylori have a role to play?, Gastroenterology Report, published 08 February 2018. https://doi.org/10.1093/gastro/goy001

Comments are closed here.


Related Articles

New Biomarker for MS Discovered; Could Replace MRI for Detection

BALTIMORE—A University of Maryland research team has discovered a biomarker that can determine whether a patients has multiple sclerosis or is relapsing, thanks to VA funding. Now two VA organizations focused on technology transfer are... View Article

VA: Blue Water Veterans Must Wait Until 2020 for Claims to Be Processed

Vietnam Vets on Ships Won Fight for Presumptive Agent Orange Status WASHINGTON—Blue Water Navy veterans who want to file disability claims related to Agent Orange exposure will have to wait until next year to have... View Article


U.S. Medicine Recommends


More From oncology

Oncology

Racial Disparities Found in BRCA Testing, Counseling

DURHAM, NC—Despite increases in BRCA mutation testing, racial/ethnic disparities in counseling and testing have persisted for decades, a study argued. The review published in the Journal of Racial and Ethnic Health Disparities said its purpose... View Article

Oncology

VA Guideline Addresses Dental Management of Head/Neck Cancer Patients

SAN FRANCISCO—Few protocols have been published for the dental management of patients with head and neck cancer to prevent complications from head and neck radiation therapy, according to a new study.  The report in the... View Article

Oncology

Patients Treated with Thiopurines Have Higher Skin Cancer Mortality

PHILADELPHIA—Treatment with thiopurines is associated with an increased risk of squamous cell carcinoma of the skin in patients with inflammatory bowel diseases. An article in Clinical Gastroenterology and Hepatology discussed results of a study that... View Article

Oncology

Overcoming Radiation Resistant Prostate Cancer

LOS ANGELES—For nearly half of the patients with localized advanced prostate cancer, radiation therapy is the primary intervention and standard of care for recurrent disease following surgery. The problem is that nearly 30% to 50%... View Article

Oncology

JAK Enzymes Can Treat Leukemia, Lymphoma

NASHVILLE, TN—Precision oncology prescribes the use of molecularly-targeted therapy directed by identification of genomic alterations. A new study suggested the approach is particularly applicable to neoplasms that are resistant to standard cytotoxic chemotherapy, such as... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up